Research Article
[Retracted] Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma
Table 2
KEGG pathway of the potential therapeutic targets.
| Serial number | Term | Count | value | FDR |
| hsa05200 | Pathways in cancer | 52 | 8.80-34 | 8.18-32 | hsa05161 | Hepatitis B | 35 | 7.47-31 | 3.47-29 | hsa04210 | Apoptosis | 25 | 1.04-27 | 3.23-26 | hsa05205 | Proteoglycans in cancer | 29 | 6.79-19 | 1.58-17 | hsa04668 | TNF signaling pathway | 23 | 1.18-18 | 2.20-17 | hsa05210 | Colorectal cancer | 19 | 2.58-18 | 4.00-17 | hsa05145 | Toxoplasmosis | 22 | 3.92-17 | 5.20-16 | hsa05142 | Chagas disease (American trypanosomiasis) | 21 | 2.03-16 | 2.36-15 | hsa05222 | Small cell lung cancer | 19 | 1.32-15 | 1.36-14 | hsa04064 | NF-kappa B signaling pathway | 18 | 3.49-14 | 3.25-13 | hsa04620 | Toll-like receptor signaling pathway | 19 | 7.66-14 | 6.42-13 | hsa05152 | Tuberculosis | 23 | 8.29-14 | 6.42-13 | hsa04932 | Nonalcoholic fatty liver disease (NAFLD) | 21 | 3.75-13 | 2.69-12 | hsa05133 | Pertussis | 16 | 8.68-13 | 5.77-12 | hsa05219 | Bladder cancer | 13 | 1.40-12 | 8.68-12 | hsa04115 | p53 signaling pathway | 15 | 2.78-12 | 1.62-11 | hsa04621 | NOD-like receptor signaling pathway | 14 | 4.14-12 | 2.25-11 | hsa05160 | Hepatitis C | 19 | 4.36-12 | 2.25-11 | hsa05164 | Influenza A | 21 | 5.62-12 | 2.75-11 | hsa04722 | Neurotrophin signaling pathway | 18 | 8.52-12 | 3.96-11 |
|
|
KEGG: Kyoto Encyclopedia of Genes and Genomes; FDR: false discovery rate.
|